Platinum IV Complex Enabling Multiple and Potent Tumor Microenvironment Remodeling for Cancer Chemo-Immunotherapy
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c03032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Rensong Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, Dalian University of Technology, Dalian 116024, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Antineoplastic Agents, Immunotherapy, Organoplatinum Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor microenvironment not only compromises the therapeutic efficacy of chemotherapy but also weakens chemotherapy-induced immunogenic cell death. Herein, we report novel platinum IV prodrugs that integrate two clinically approved drugs with different but complementary mechanisms, where cisplatin provides tumor cytotoxicity while the pirfenidone analogue contributes to tumor microenvironment modulation. In vitro evaluations suggested their superior anticancer activity, improved resistance profiles, and favorable selectivity across multiple cancer cell lines. Mechanistic studies revealed that they not only depleted intracellular glutathione and suppressed P-gp expression but also remodeled the tumor microenvironment through multiple actions. Notably, they triggered the release of damage-associated molecular patterns (DAMPs), promoted dendritic cell maturation, and induced strong immunogenic cell death despite that cisplatin is unable to induce an immunological response. In vivo studies further confirmed their antitumor activity (3.3-fold tumor inhibition compared to cisplatin) and favorable safety profile (64% weight loss by cisplatin, none with platinum IV complexes).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, Dalian University of Technology, Dalian 116024, China.
- Department of Thoracic Oncology (1), Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.
- Department of Chemistry, Bilkent University, Ankara 06800, Turkey.
ORCID-Profile: Wen Sun, Engin U Akkaya, Lei Wang
Förderung
- Liaoning Revitalization Talents Program
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Sun, R., Chen, Z., Yang, R., Liang, Y., Sun, W., Akkaya, E. U., & Wang, L. (2026). Platinum IV Complex Enabling Multiple and Potent Tumor Microenvironment Remodeling for Cancer Chemo-Immunotherapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03032
Vancouver
Sun R, Chen Z, Yang R, Liang Y, Sun W, Akkaya EU, et al. Platinum IV Complex Enabling Multiple and Potent Tumor Microenvironment Remodeling for Cancer Chemo-Immunotherapy. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03032
BibTeX
@article{Sun2026,
author = {Sun, Rensong and Chen, Zhihao and Yang, Ruitao and Liang, Yuan and Sun, Wen and Akkaya, Engin U and Wang, Lei},
title = {Platinum IV Complex Enabling Multiple and Potent Tumor Microenvironment Remodeling for Cancer Chemo-Immunotherapy},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c03032}
}
EUVIMED